In a relief for cancer patients across the country, revised maximum retail prices (MRPs) of 1,364 anti-cancer formulations have come into effect from November 9, 2026. This step has been taken by the National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
With this decision of the government, cancer drugs have become significantly cheaper, and consumers are estimated to save about Rs 3,540.38 crore annually. Based on the recommendations of an expert committee constituted by the Directorate General of Health Services on October 17, 2026, the trade margin for 137 anti-cancer drugs was capped.
Major price cuts and data
According to the NPPA, as of November 8, 2026, 85 pharmaceutical companies have reported revised prices for 1,364 anti-cancer formulations associated with 121 drugs. Out of these, 679 brands have slashed prices by more than 50 percent. A maximum reduction of up to 96.45 percent has been recorded in the MRP of medicines.
Important for you
- Consumers can check the revised MRP printed on the medicine pack.
- To verify prices, the 'Pharma Sahi Dam' mobile app or the NPPA website nppa.gov.in can be used.
- No chemist or hospital pharmacy can charge a price higher than the fixed MRP.
- In case of overcharging, complaints can be lodged on the 'Pharma Jan Samadhan' portal or the NPPA helpline number 1800-111-255.